CN Stock MarketDetailed Quotes

000766 Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

Watchlist

16.15
-0.44-2.65%

Trading Jul 15 11:13 CST

15.61BMarket Cap336.46P/E (TTM)

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(Q3)Mar 31, 2022

(FY)Dec 31, 2021

Assets

Current assets

Money funds

11.40%244.56M

-47.32%177.45M

-34.27%181.01M

-17.86%229.11M

-15.05%219.53M

11.68%336.82M

-19.07%275.38M

-27.28%278.91M

-43.09%258.43M

-40.64%301.59M

Transactional financial assets

777.77%1.07M

716.68%1.05M

2.76%108.55K

-16.74%116.14K

-25.62%121.97K

-28.80%128.39K

--105.63K

--139.48K

--163.99K

--180.33K

Notes receivable and accounts receivable

38.25%508.53M

17.26%502.11M

10.62%425.56M

5.63%437.53M

-13.85%367.82M

22.11%428.19M

9.10%384.7M

1.10%414.2M

-20.57%426.97M

-19.32%350.66M

-Notes receivable

4.52%3.22M

23.61%5.29M

14.38%3.49M

78.23%989.66K

--3.09M

8,459.85%4.28M

--3.05M

--555.28K

----

--50K

-Accounts receivable

38.54%505.3M

17.20%496.82M

10.59%422.06M

5.54%436.54M

-14.58%364.73M

20.91%423.91M

8.24%381.65M

0.97%413.64M

-20.57%426.97M

-19.33%350.61M

Other receivables (including interest and dividends)

4.74%48.02M

-2.63%34.81M

-49.77%26.49M

-35.50%41.03M

-16.36%45.85M

-23.91%35.75M

-25.04%52.74M

-24.62%63.61M

-48.60%54.82M

-49.60%46.99M

-Dividend receivable

----

--12.72M

----

-Other receivable

----

-19.37%41.03M

----

-23.91%35.75M

----

-39.70%50.89M

----

-49.60%46.99M

Advance payment

-4.60%11.12M

-41.39%8.03M

30.64%14.47M

-12.03%12.56M

-12.65%11.66M

106.52%13.71M

-7.20%11.08M

13.48%14.28M

21.26%13.35M

-46.72%6.64M

Inventories

-4.24%385.05M

-3.20%369.17M

2.17%385.05M

2.81%378.22M

9.48%402.09M

-0.83%381.37M

-8.51%376.89M

-9.96%367.89M

-11.51%367.26M

-11.64%384.58M

Receivable financing

-3.24%14.02M

-56.91%18.2M

15.04%16.17M

73.49%8.57M

-11.91%14.49M

-9.12%42.23M

-49.51%14.05M

-76.79%4.94M

-16.52%16.45M

91.10%46.47M

Other current assets

-41.60%93.14K

141.48%397.2K

-92.47%161.5K

-96.19%164.49K

-98.71%159.49K

-98.87%164.49K

-88.72%2.15M

-79.98%4.32M

-41.53%12.38M

-30.93%14.58M

Total current assets

14.20%1.21B

-10.27%1.11B

-6.09%1.05B

-3.57%1.11B

-7.66%1.06B

7.53%1.24B

-9.47%1.12B

-14.41%1.15B

-26.54%1.15B

-24.68%1.15B

Non Current assets

Other equity investment

0.00%1.91B

Other non-current financial assets

0.00%18.77M

0.16%18.77M

Long-term equity investment

-6.01%53M

-6.63%52.68M

9.32%57.46M

-1.56%53.73M

2.32%56.39M

0.71%56.43M

-4.75%52.56M

-4.76%54.58M

-2.74%55.11M

-2.41%56.03M

Fixed assets

----

-5.59%744.75M

----

-5.41%767.03M

----

-4.90%788.82M

----

12.51%810.9M

Constru in process

----

2.94%274.32M

----

3.18%267.39M

----

4.38%266.48M

----

-4.44%259.15M

Productive biological assets

18.77%16.96M

20.70%16.93M

25.44%16.84M

26.72%16.63M

9.77%14.28M

9.84%14.03M

6.26%13.42M

4.35%13.13M

3.97%13.01M

2.40%12.77M

Intangible assets

-6.85%197.72M

-6.90%201.67M

-6.60%205.71M

-7.40%208.06M

-7.32%212.27M

-7.19%216.61M

-7.03%220.26M

-6.90%224.68M

-7.04%229.04M

-6.66%233.4M

Development expenditure

7.60%173.96M

7.54%172.18M

5.50%166.35M

5.64%163.49M

4.58%161.67M

5.09%160.11M

7.23%157.67M

5.87%154.77M

6.68%154.58M

9.03%152.36M

Goodwill

0.00%1.9M

-0.38%1.9M

0.00%1.91M

Long deferred expense

59.03%1.17M

64.10%1.28M

68.62%1.39M

-20.69%688.08K

-20.97%732.95K

-18.75%777.83K

-18.17%822.7K

-17.76%867.58K

-30.50%927.41K

-39.07%957.33K

Deferred tax assets

-17.83%12.53M

-7.43%13.6M

-12.52%14.99M

-13.76%14.97M

-24.26%15.25M

-24.03%14.69M

-16.87%17.14M

-20.28%17.36M

-57.67%20.13M

-58.71%19.33M

Usufruct assets

20.85%4.25M

12.40%4.83M

-50.87%1.81M

-51.01%1.84M

-8.53%3.52M

9.44%4.3M

--3.68M

--3.76M

--3.84M

-7.71%3.92M

Other non current assets

-33.16%6.97M

-44.18%5.85M

-0.48%10.05M

58.08%13.46M

27.77%10.43M

95.18%10.47M

-1.85%10.1M

-1.57%8.51M

-11.20%8.16M

-59.17%5.37M

Total non current assets

-1.34%3.39B

-1.12%3.41B

-1.09%3.42B

-1.18%3.43B

-1.33%3.44B

-1.21%3.45B

-1.11%3.45B

-1.16%3.47B

1.28%3.49B

1.07%3.49B

Total assets

2.32%4.61B

-3.54%4.52B

-2.31%4.47B

-1.78%4.53B

-2.90%4.5B

0.96%4.69B

-3.29%4.57B

-4.82%4.62B

-7.42%4.63B

-6.84%4.64B

Liabilities

Current liabilities

Short term loan

73.04%225.15M

419.77%130.16M

225.29%130.12M

-37.48%25.04M

-11.11%40M

-68.02%40M

-68.00%40.06M

Notes payable and accounts payable

-18.07%167.11M

-13.88%191M

38.33%225.4M

28.03%228.66M

25.17%203.98M

47.28%221.79M

0.10%162.94M

4.13%178.6M

-19.53%162.96M

-19.87%150.59M

-Notes payable

22.90%7.1M

21.91%7.65M

65.32%8.27M

53.31%3.87M

200.88%5.78M

226.86%6.28M

1,329.48%5M

--2.52M

--1.92M

-Accounts payable

-19.27%160.01M

-14.92%183.35M

37.48%217.12M

27.67%224.79M

23.08%198.2M

44.96%215.51M

-2.76%157.94M

2.66%176.08M

-20.47%161.04M

-20.90%148.67M

Contract liabilities

-4.07%13.02M

-70.69%11.66M

103.65%20.08M

106.61%14.26M

40.86%13.58M

245.98%39.79M

-32.91%9.86M

-61.56%6.9M

-60.18%9.64M

-55.29%11.5M

Salaries payable

-3.27%16.92M

-24.21%17.05M

-5.15%17.75M

-5.56%17.99M

-8.12%17.49M

14.26%22.5M

-11.82%18.71M

12.78%19.06M

3.71%19.04M

1.37%19.69M

Taxs payable

6.94%12.94M

-34.91%20.37M

-24.62%16.98M

-30.72%16.04M

-40.75%12.1M

56.83%31.3M

117.98%22.52M

95.66%23.15M

106.14%20.43M

-1.88%19.96M

Other payable (including interest and dividends)

87.84%196.89M

52.77%188.21M

-10.14%100.21M

-20.72%109.24M

-36.38%104.82M

-22.78%123.2M

-31.19%111.52M

-35.30%137.78M

-37.05%164.77M

-25.47%159.55M

-Dividend payable

0.00%3.59M

-Other payable

----

-21.27%105.65M

----

-23.31%119.61M

----

-35.91%134.19M

----

-25.91%155.95M

Non current liabilities due within one year

--8.67M

-93.72%12.86M

-99.96%75.84K

-100.00%57.15K

----

-87.39%204.88M

-54.00%195.87M

972.80%1.78B

944.68%1.78B

861.58%1.63B

Other current liabilities

-33.73%853.3K

-65.13%1.17M

102.52%1.4M

120.38%1.1M

83.47%1.29M

187.38%3.37M

-43.00%690.23K

-60.96%500.57K

-39.56%701.78K

-44.47%1.17M

Total current liabilities

32.73%641.57M

-14.79%572.49M

-8.91%512M

-76.31%517.48M

-78.05%483.38M

-66.86%671.86M

-33.33%562.11M

239.58%2.18B

170.57%2.2B

165.47%2.03B

Current liabilities

Long term loan

0.21%1.57B

-0.40%1.56B

-0.78%1.56B

--1.56B

750.91%1.56B

6.74%1.58B

----

-89.87%183.75M

Deferred tax liabilities

-2.80%4.14M

-11.72%4.36M

-26.60%3.97M

-41.14%3.59M

-37.39%4.26M

-32.38%4.94M

-28.80%5.41M

-24.91%6.11M

-22.24%6.8M

-17.96%7.3M

Long term deferred income

-10.09%63.01M

-9.85%64.75M

-9.60%66.6M

-9.38%68.34M

-9.07%70.08M

-8.96%71.83M

-8.64%73.67M

-8.98%75.41M

-8.03%77.08M

-7.58%78.9M

Lease liabilities

-47.00%2.14M

-51.76%2.14M

-41.75%2.32M

-39.67%2.37M

-5.02%4.03M

11.51%4.44M

--3.98M

--3.93M

--4.25M

0.29%3.98M

Total non current liabilities

-0.35%1.64B

-0.98%1.63B

-1.35%1.64B

1,816.67%1.64B

1,763.23%1.64B

500.43%1.64B

6.03%1.66B

-95.45%85.45M

-95.32%88.12M

-85.67%273.93M

Total liabilities

7.17%2.28B

-4.99%2.2B

-3.27%2.15B

-5.04%2.16B

-7.19%2.13B

0.66%2.32B

-7.75%2.22B

-10.02%2.27B

-15.10%2.29B

-13.99%2.3B

Shareholders equity

Paid-in capital

0.00%966.49M

Capital reserve funds

-1.73%3.58B

-0.96%3.61B

0.00%3.64B

Surplus reserve funds

0.00%108.65M

Retained profit

1.94%-2.33B

1.85%-2.34B

1.39%-2.37B

1.30%-2.37B

1.25%-2.38B

1.31%-2.4B

0.82%-2.4B

1.51%-2.41B

1.44%-2.41B

Shareholders equity without minority interests

-0.72%2.33B

-0.82%2.32B

-0.08%2.32B

1.44%2.35B

1.35%2.34B

1.31%2.34B

1.40%2.32B

0.86%2.31B

1.63%2.31B

1.55%2.31B

Minority interests

-98.59%443.77K

-98.53%464.26K

-98.51%473.31K

-3.05%31.17M

-3.08%31.4M

-2.95%31.64M

-3.03%31.87M

-3.21%32.15M

-3.43%32.4M

-3.79%32.6M

Total shareholder equity

-2.02%2.33B

-2.13%2.32B

-1.41%2.32B

1.38%2.38B

1.29%2.38B

1.25%2.37B

1.33%2.35B

0.81%2.35B

1.55%2.34B

1.47%2.34B

Total liabilityies and equity

2.32%4.61B

-3.54%4.52B

-2.31%4.47B

-1.78%4.53B

-2.90%4.5B

0.96%4.69B

-3.29%4.57B

-4.82%4.62B

-7.42%4.63B

-6.84%4.64B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Zhongzhu Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(Q3)Mar 31, 2022	(FY)Dec 31, 2021
Assets
Current assets
Money funds	11.40%244.56M	-47.32%177.45M	-34.27%181.01M	-17.86%229.11M	-15.05%219.53M	11.68%336.82M	-19.07%275.38M	-27.28%278.91M	-43.09%258.43M	-40.64%301.59M
Transactional financial assets	777.77%1.07M	716.68%1.05M	2.76%108.55K	-16.74%116.14K	-25.62%121.97K	-28.80%128.39K	--105.63K	--139.48K	--163.99K	--180.33K
Notes receivable and accounts receivable	38.25%508.53M	17.26%502.11M	10.62%425.56M	5.63%437.53M	-13.85%367.82M	22.11%428.19M	9.10%384.7M	1.10%414.2M	-20.57%426.97M	-19.32%350.66M
-Notes receivable	4.52%3.22M	23.61%5.29M	14.38%3.49M	78.23%989.66K	--3.09M	8,459.85%4.28M	--3.05M	--555.28K	----	--50K
-Accounts receivable	38.54%505.3M	17.20%496.82M	10.59%422.06M	5.54%436.54M	-14.58%364.73M	20.91%423.91M	8.24%381.65M	0.97%413.64M	-20.57%426.97M	-19.33%350.61M
Other receivables (including interest and dividends)	4.74%48.02M	-2.63%34.81M	-49.77%26.49M	-35.50%41.03M	-16.36%45.85M	-23.91%35.75M	-25.04%52.74M	-24.62%63.61M	-48.60%54.82M	-49.60%46.99M
-Dividend receivable	----	----	----	----	----	----	----	--12.72M	----	----
-Other receivable	----	----	----	-19.37%41.03M	----	-23.91%35.75M	----	-39.70%50.89M	----	-49.60%46.99M
Advance payment	-4.60%11.12M	-41.39%8.03M	30.64%14.47M	-12.03%12.56M	-12.65%11.66M	106.52%13.71M	-7.20%11.08M	13.48%14.28M	21.26%13.35M	-46.72%6.64M
Inventories	-4.24%385.05M	-3.20%369.17M	2.17%385.05M	2.81%378.22M	9.48%402.09M	-0.83%381.37M	-8.51%376.89M	-9.96%367.89M	-11.51%367.26M	-11.64%384.58M
Receivable financing	-3.24%14.02M	-56.91%18.2M	15.04%16.17M	73.49%8.57M	-11.91%14.49M	-9.12%42.23M	-49.51%14.05M	-76.79%4.94M	-16.52%16.45M	91.10%46.47M
Other current assets	-41.60%93.14K	141.48%397.2K	-92.47%161.5K	-96.19%164.49K	-98.71%159.49K	-98.87%164.49K	-88.72%2.15M	-79.98%4.32M	-41.53%12.38M	-30.93%14.58M
Total current assets	14.20%1.21B	-10.27%1.11B	-6.09%1.05B	-3.57%1.11B	-7.66%1.06B	7.53%1.24B	-9.47%1.12B	-14.41%1.15B	-26.54%1.15B	-24.68%1.15B
Non Current assets
Other equity investment	0.00%1.91B	0.00%1.91B	0.00%1.91B	0.00%1.91B	0.00%1.91B	0.00%1.91B	0.00%1.91B	0.00%1.91B	0.00%1.91B	0.00%1.91B
Other non-current financial assets	0.00%18.77M	0.00%18.77M	0.00%18.77M	0.00%18.77M	0.00%18.77M	0.00%18.77M	0.16%18.77M	0.16%18.77M	0.16%18.77M	0.16%18.77M
Long-term equity investment	-6.01%53M	-6.63%52.68M	9.32%57.46M	-1.56%53.73M	2.32%56.39M	0.71%56.43M	-4.75%52.56M	-4.76%54.58M	-2.74%55.11M	-2.41%56.03M
Fixed assets	----	----	----	-5.59%744.75M	----	-5.41%767.03M	----	-4.90%788.82M	----	12.51%810.9M
Constru in process	----	----	----	2.94%274.32M	----	3.18%267.39M	----	4.38%266.48M	----	-4.44%259.15M
Productive biological assets	18.77%16.96M	20.70%16.93M	25.44%16.84M	26.72%16.63M	9.77%14.28M	9.84%14.03M	6.26%13.42M	4.35%13.13M	3.97%13.01M	2.40%12.77M
Intangible assets	-6.85%197.72M	-6.90%201.67M	-6.60%205.71M	-7.40%208.06M	-7.32%212.27M	-7.19%216.61M	-7.03%220.26M	-6.90%224.68M	-7.04%229.04M	-6.66%233.4M
Development expenditure	7.60%173.96M	7.54%172.18M	5.50%166.35M	5.64%163.49M	4.58%161.67M	5.09%160.11M	7.23%157.67M	5.87%154.77M	6.68%154.58M	9.03%152.36M
Goodwill	0.00%1.9M	0.00%1.9M	0.00%1.9M	0.00%1.9M	-0.38%1.9M	-0.38%1.9M	-0.38%1.9M	-0.38%1.9M	0.00%1.91M	0.00%1.91M
Long deferred expense	59.03%1.17M	64.10%1.28M	68.62%1.39M	-20.69%688.08K	-20.97%732.95K	-18.75%777.83K	-18.17%822.7K	-17.76%867.58K	-30.50%927.41K	-39.07%957.33K
Deferred tax assets	-17.83%12.53M	-7.43%13.6M	-12.52%14.99M	-13.76%14.97M	-24.26%15.25M	-24.03%14.69M	-16.87%17.14M	-20.28%17.36M	-57.67%20.13M	-58.71%19.33M
Usufruct assets	20.85%4.25M	12.40%4.83M	-50.87%1.81M	-51.01%1.84M	-8.53%3.52M	9.44%4.3M	--3.68M	--3.76M	--3.84M	-7.71%3.92M
Other non current assets	-33.16%6.97M	-44.18%5.85M	-0.48%10.05M	58.08%13.46M	27.77%10.43M	95.18%10.47M	-1.85%10.1M	-1.57%8.51M	-11.20%8.16M	-59.17%5.37M
Total non current assets	-1.34%3.39B	-1.12%3.41B	-1.09%3.42B	-1.18%3.43B	-1.33%3.44B	-1.21%3.45B	-1.11%3.45B	-1.16%3.47B	1.28%3.49B	1.07%3.49B
Total assets	2.32%4.61B	-3.54%4.52B	-2.31%4.47B	-1.78%4.53B	-2.90%4.5B	0.96%4.69B	-3.29%4.57B	-4.82%4.62B	-7.42%4.63B	-6.84%4.64B
Liabilities
Current liabilities
Short term loan	73.04%225.15M	419.77%130.16M	225.29%130.12M	225.29%130.12M	225.29%130.12M	-37.48%25.04M	-11.11%40M	-11.11%40M	-68.02%40M	-68.00%40.06M
Notes payable and accounts payable	-18.07%167.11M	-13.88%191M	38.33%225.4M	28.03%228.66M	25.17%203.98M	47.28%221.79M	0.10%162.94M	4.13%178.6M	-19.53%162.96M	-19.87%150.59M
-Notes payable	22.90%7.1M	21.91%7.65M	65.32%8.27M	53.31%3.87M	200.88%5.78M	226.86%6.28M	1,329.48%5M	--2.52M	--1.92M	--1.92M
-Accounts payable	-19.27%160.01M	-14.92%183.35M	37.48%217.12M	27.67%224.79M	23.08%198.2M	44.96%215.51M	-2.76%157.94M	2.66%176.08M	-20.47%161.04M	-20.90%148.67M
Contract liabilities	-4.07%13.02M	-70.69%11.66M	103.65%20.08M	106.61%14.26M	40.86%13.58M	245.98%39.79M	-32.91%9.86M	-61.56%6.9M	-60.18%9.64M	-55.29%11.5M
Salaries payable	-3.27%16.92M	-24.21%17.05M	-5.15%17.75M	-5.56%17.99M	-8.12%17.49M	14.26%22.5M	-11.82%18.71M	12.78%19.06M	3.71%19.04M	1.37%19.69M
Taxs payable	6.94%12.94M	-34.91%20.37M	-24.62%16.98M	-30.72%16.04M	-40.75%12.1M	56.83%31.3M	117.98%22.52M	95.66%23.15M	106.14%20.43M	-1.88%19.96M
Other payable (including interest and dividends)	87.84%196.89M	52.77%188.21M	-10.14%100.21M	-20.72%109.24M	-36.38%104.82M	-22.78%123.2M	-31.19%111.52M	-35.30%137.78M	-37.05%164.77M	-25.47%159.55M
-Dividend payable	0.00%3.59M	0.00%3.59M	0.00%3.59M	0.00%3.59M	0.00%3.59M	0.00%3.59M	0.00%3.59M	0.00%3.59M	0.00%3.59M	0.00%3.59M
-Other payable	----	----	----	-21.27%105.65M	----	-23.31%119.61M	----	-35.91%134.19M	----	-25.91%155.95M
Non current liabilities due within one year	--8.67M	-93.72%12.86M	-99.96%75.84K	-100.00%57.15K	----	-87.39%204.88M	-54.00%195.87M	972.80%1.78B	944.68%1.78B	861.58%1.63B
Other current liabilities	-33.73%853.3K	-65.13%1.17M	102.52%1.4M	120.38%1.1M	83.47%1.29M	187.38%3.37M	-43.00%690.23K	-60.96%500.57K	-39.56%701.78K	-44.47%1.17M
Total current liabilities	32.73%641.57M	-14.79%572.49M	-8.91%512M	-76.31%517.48M	-78.05%483.38M	-66.86%671.86M	-33.33%562.11M	239.58%2.18B	170.57%2.2B	165.47%2.03B
Current liabilities
Long term loan	0.21%1.57B	-0.40%1.56B	-0.78%1.56B	--1.56B	--1.56B	750.91%1.56B	6.74%1.58B	----	----	-89.87%183.75M
Deferred tax liabilities	-2.80%4.14M	-11.72%4.36M	-26.60%3.97M	-41.14%3.59M	-37.39%4.26M	-32.38%4.94M	-28.80%5.41M	-24.91%6.11M	-22.24%6.8M	-17.96%7.3M
Long term deferred income	-10.09%63.01M	-9.85%64.75M	-9.60%66.6M	-9.38%68.34M	-9.07%70.08M	-8.96%71.83M	-8.64%73.67M	-8.98%75.41M	-8.03%77.08M	-7.58%78.9M
Lease liabilities	-47.00%2.14M	-51.76%2.14M	-41.75%2.32M	-39.67%2.37M	-5.02%4.03M	11.51%4.44M	--3.98M	--3.93M	--4.25M	0.29%3.98M
Total non current liabilities	-0.35%1.64B	-0.98%1.63B	-1.35%1.64B	1,816.67%1.64B	1,763.23%1.64B	500.43%1.64B	6.03%1.66B	-95.45%85.45M	-95.32%88.12M	-85.67%273.93M
Total liabilities	7.17%2.28B	-4.99%2.2B	-3.27%2.15B	-5.04%2.16B	-7.19%2.13B	0.66%2.32B	-7.75%2.22B	-10.02%2.27B	-15.10%2.29B	-13.99%2.3B
Shareholders equity
Paid-in capital	0.00%966.49M	0.00%966.49M	0.00%966.49M	0.00%966.49M	0.00%966.49M	0.00%966.49M	0.00%966.49M	0.00%966.49M	0.00%966.49M	0.00%966.49M
Capital reserve funds	-1.73%3.58B	-1.73%3.58B	-0.96%3.61B	0.00%3.64B	0.00%3.64B	0.00%3.64B	0.00%3.64B	0.00%3.64B	0.00%3.64B	0.00%3.64B
Surplus reserve funds	0.00%108.65M	0.00%108.65M	0.00%108.65M	0.00%108.65M	0.00%108.65M	0.00%108.65M	0.00%108.65M	0.00%108.65M	0.00%108.65M	0.00%108.65M
Retained profit	1.94%-2.33B	1.85%-2.34B	1.39%-2.37B	1.39%-2.37B	1.30%-2.37B	1.25%-2.38B	1.31%-2.4B	0.82%-2.4B	1.51%-2.41B	1.44%-2.41B
Shareholders equity without minority interests	-0.72%2.33B	-0.82%2.32B	-0.08%2.32B	1.44%2.35B	1.35%2.34B	1.31%2.34B	1.40%2.32B	0.86%2.31B	1.63%2.31B	1.55%2.31B
Minority interests	-98.59%443.77K	-98.53%464.26K	-98.51%473.31K	-3.05%31.17M	-3.08%31.4M	-2.95%31.64M	-3.03%31.87M	-3.21%32.15M	-3.43%32.4M	-3.79%32.6M
Total shareholder equity	-2.02%2.33B	-2.13%2.32B	-1.41%2.32B	1.38%2.38B	1.29%2.38B	1.25%2.37B	1.33%2.35B	0.81%2.35B	1.55%2.34B	1.47%2.34B
Total liabilityies and equity	2.32%4.61B	-3.54%4.52B	-2.31%4.47B	-1.78%4.53B	-2.90%4.5B	0.96%4.69B	-3.29%4.57B	-4.82%4.62B	-7.42%4.63B	-6.84%4.64B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	Zhongzhu Certified Public Accountants (Special General Partnership)	--	--	--	Zhongzhu Certified Public Accountants (Special General Partnership)	--	--	--	Zhongzhu Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

000766 Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target